These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 24344810)

  • 1. Short- and long-term clinical skin effects of testosterone treatment in trans men.
    Wierckx K; Van de Peer F; Verhaeghe E; Dedecker D; Van Caenegem E; Toye K; Kaufman JM; T'Sjoen G
    J Sex Med; 2014 Jan; 11(1):222-9. PubMed ID: 24344810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-sex hormone therapy in trans persons is safe and effective at short-time follow-up: results from the European network for the investigation of gender incongruence.
    Wierckx K; Van Caenegem E; Schreiner T; Haraldsen I; Fisher AD; Toye K; Kaufman JM; T'Sjoen G
    J Sex Med; 2014 Aug; 11(8):1999-2011. PubMed ID: 24828032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dermatologic Conditions in Transgender Populations.
    Yeung H; Kahn B; Ly BC; Tangpricha V
    Endocrinol Metab Clin North Am; 2019 Jun; 48(2):429-440. PubMed ID: 31027550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of hormonal treatment on dermatological outcome in transgender people: a multicentric prospective study (ENIGI).
    Cocchetti C; Castellini G; Maggi M; Romani A; Vignozzi L; Greenman Y; den Heijer M; T'Sjoen G; Fisher AD
    J Endocrinol Invest; 2023 Apr; 46(4):779-786. PubMed ID: 36348253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythrocytosis in a Large Cohort of Trans Men Using Testosterone: A Long-Term Follow-Up Study on Prevalence, Determinants, and Exposure Years.
    Madsen MC; van Dijk D; Wiepjes CM; Conemans EB; Thijs A; den Heijer M
    J Clin Endocrinol Metab; 2021 May; 106(6):1710-1717. PubMed ID: 33599731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of sex steroid deprivation/administration on hair growth and skin sebum production in transsexual males and females.
    Giltay EJ; Gooren LJ
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2913-21. PubMed ID: 10946903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testosterone therapy for transgender men.
    Irwig MS
    Lancet Diabetes Endocrinol; 2017 Apr; 5(4):301-311. PubMed ID: 27084565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transgender men: clinical care and implications in reproductive medicine: introduction.
    de Ziegler D; de Sutter P
    Fertil Steril; 2021 Oct; 116(4):919-921. PubMed ID: 34399947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testosterone and other treatments for transgender males and non-binary trans masculine individuals.
    Dimakopoulou A; Seal LJ
    Best Pract Res Clin Endocrinol Metab; 2024 Sep; 38(5):101908. PubMed ID: 38997938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian, breast, and metabolic changes induced by androgen treatment in transgender men.
    Pirtea P; Ayoubi JM; Desmedt S; T'Sjoen G
    Fertil Steril; 2021 Oct; 116(4):936-942. PubMed ID: 34481638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of testosterone on chests and abdomens of transgender men.
    Motosko CC; Zakhem GA; Pomeranz MK; Pomerantz R; Saadeh PB; Gothard MD; Hazen A
    J Am Acad Dermatol; 2019 Aug; 81(2):634-636. PubMed ID: 30685270
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy of topical minoxidil in enhancing beard growth in a group of transgender assigned female at birth individuals on gender affirming hormone therapy.
    Marinelli L; Bichiri A; Cagnina S; Castella L; Ghigo E; Motta G
    J Endocrinol Invest; 2024 Nov; 47(11):2843-2850. PubMed ID: 38644453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and rapid efficacy of guideline-based gender-affirming hormone therapy: an analysis of 388 individuals diagnosed with gender dysphoria.
    Meyer G; Mayer M; Mondorf A; Flügel AK; Herrmann E; Bojunga J
    Eur J Endocrinol; 2020 Feb; 182(2):149-156. PubMed ID: 31751300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects on Voice Fundamental Frequency and Satisfaction with Voice in Trans Men during Testosterone Treatment-A Longitudinal Study.
    Nygren U; Nordenskjöld A; Arver S; Södersten M
    J Voice; 2016 Nov; 30(6):766.e23-766.e34. PubMed ID: 26678122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocrinology of Transgender Medicine.
    T'Sjoen G; Arcelus J; Gooren L; Klink DT; Tangpricha V
    Endocr Rev; 2019 Feb; 40(1):97-117. PubMed ID: 30307546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physical changes, laboratory parameters, and bone mineral density during testosterone treatment in adolescents with gender dysphoria.
    Stoffers IE; de Vries MC; Hannema SE
    J Sex Med; 2019 Sep; 16(9):1459-1468. PubMed ID: 31405768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterizing Dermatological Conditions in the Transgender Population: A Cross-Sectional Study.
    Rutnin S; Suchonwanit P; Kositkuljorn C; Pomsoong C; Korpaisarn S; Arunakul J; Rattananukrom T
    Transgend Health; 2023 Feb; 8(1):89-99. PubMed ID: 36824384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone mass, bone geometry, and body composition in female-to-male transsexual persons after long-term cross-sex hormonal therapy.
    Van Caenegem E; Wierckx K; Taes Y; Dedecker D; Van de Peer F; Toye K; Kaufman JM; T'Sjoen G
    J Clin Endocrinol Metab; 2012 Jul; 97(7):2503-11. PubMed ID: 22564669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent vaginal bleeding during gender-affirming hormone therapy in transgender men.
    da Silva ED; Spritzer PM; Fighera TM
    J Endocrinol Invest; 2024 Aug; 47(8):2053-2060. PubMed ID: 38300501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acne severity and the Global Acne Grading System in polycystic ovary syndrome.
    Hacivelioglu S; Gungor AN; Gencer M; Uysal A; Hizli D; Koc E; Cosar E
    Int J Gynaecol Obstet; 2013 Oct; 123(1):33-6. PubMed ID: 23948280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.